Defining practice patterns in Gynecologic Oncology to prevent pulmonary embolism and deep venous thrombosis

Gynecologic Oncology

Volumn 106, Issue 3, 2007, Pages 439-445

  Martino, M A ^a   Williamson, E ^b   Rajaram, L ^c   Lancaster, J M ^b   Hoffman, M S ^b   Maxwell, G L ^d   Clarke Pearson, D L ^e  

^a LEHIGH VALLEY HOSPITAL   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d WALTER REED ARMY MEDICAL CENTER   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Deep venous thrombosis; Heparin; Pneumatic; Prophylaxis; Pulmonary embolism; Thromboembolism

Indexed keywords

DALTEPARIN; ENOXAPARIN; FONDAPARINUX; HEPARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; CANCER PATIENT; CANCER RISK; COMPRESSION THERAPY; DATA COLLECTION METHOD; DEEP VEIN THROMBOSIS; FEMALE; GYNECOLOGIC CANCER; HEALTH SURVEY; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; OVARY CANCER; PRIORITY JOURNAL; THROMBOSIS PREVENTION;

ADULT; AGED; ANTICOAGULANTS; FEMALE; GENITAL NEOPLASMS, FEMALE; GYNECOLOGY; HUMANS; INTERMITTENT PNEUMATIC COMPRESSION DEVICES; MEDICAL ONCOLOGY; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PULMONARY EMBOLISM; VENOUS THROMBOSIS;

EID: 34548140640     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.05.001     Document Type: Article

References (33)

1. Walsh J.J., Bonnar J., and Wright F.W. A study of pulmonary embolism and deep leg thrombosis after major gynecologic surgery using labeled fibrinogen phlebography and lung scanning. J Obstet Gynaecol Br Commonw 81 (1974) 311-316
2. Crandon A.J. Knotts: incidence of post-operative thrombosis in gynecologic oncology. Aust NZ J Obstet Gynaecol 23 (1983) 216-219
3. Clarke-Pearson D.L., Jelovsek F.R., and Creasman W.T. Thromboembolism complicating surgery for cervical and uterine malignancy: incidence, risk factors and prophylaxis. Obstet Gynecol 61 (1983) 87-94
4. Polistena P., Bernardi E., and Prins M.H. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 125 (1996) 1-7
5. Goldhaber S.Z., Hennekens C.H., Evans D.A., Newton E.C., and Godleski J.J. Factors associated with correct antemortem diagnosis of major pulmonary embolism. Am J Med 73 (1982) 822-826
6. Rubenstien I., Murray D., and Hoffstein V. Fatal pulmonary emboli in hospitalized patients. Arch Intern Med 148 (1988) 1425-1426
7. Donaldson G.A., Williams C., Scannell J.G., and Shaw R.S. A reappraisal of the application of the Trendelenburg operation to massive fatal embolism: report of a successful pulmonary-artery thrombectomy using a cardiopulmonary bypass. N Engl J Med 268 (1963) 171-174
8. Geerts W.H., Pineo G.F., Heit J.A., Bergqvist D., Lassen M.R., Colwell C.W., et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 3 Suppl (Sep 2004) 338S-400S
9. Clarke-Pearson D.L., Synan I.S., Hinshaw W.M., Coleman R.E., and Creaseman E.T. Prevention of postoperative venous thromboembolism by external pneumatic calf compression in patients with gynecologic malignancy. Obstet Gynecol. 63 (1984) 92-98
10. Clarke-Pearson D.L., Synan I.S., Dodge R., Soper J.T., Berchuck A., and Coleman RE. A randomized trial of low-dose heparin and external pneumatic calf compression for the prevention of deep venous thrombosis after gynecologic oncology surgery. Am J Obstet Gynecol 168 (1993) 1146-1153
11. Maxwell G.L., Synan I., Dodge R., Carroll B., and Clarke-Pearson D.L. Pneumatic compression versus low molecular weight heparin in gynecologic oncology surgery: a randomized trial. Obstet Gynecol 98 (2001) 989-995
12. Maxwell G.L., Synan I., Hayes R., and Clarke-Pearson D. Patient preference among gynecologic oncology patients undergoing thromboembolism prophylaxis. Obstet Gynecol 100 (Sep 2002) 451-455
13. Maxwell G.L., Myers E., and Clarke-Pearson D.L. Cost-effectiveness of deep venous thrombosis prophylaxis using pneumatic compression, low-dose heparin or low molecular weight heparin in gynecologic surgery. Obstet Gynecol 95 (2000) 206-214
14. Clarke-Pearson D.L., Dodge R., Synan I., McClelland C., and Maxwell G.L. Risk factors which predispose patients to thromboembolism despite prophylaxis with external pneumatic compression'. Obstet Gynecol 101 (2003) 157-163
15. Martino M.A., Borges E., Williamson E., Siegfried S., Cantor A., Lancaster J.M., et al. Pulmonary embolism after major abdominal surgery in gynecologic oncology. Obstet. Gynecol. 107 (2006) 666-671
16. Wilson S.J., Wilbur K., Burton E., and Anderson D.R. Effect of patient weight on the anticoagulant response to adjusted therapeutic dosage of low-molecular-weight heparin for the treatment of venous thromboembolism. Haemostasis 31 (2001) 42-48
17. Green B., and Duffull S.B. Development of a dosing strategy for enoxaparin in obese patients. J Clin Pharmacol 56 (2003) 96-103
18. Al-Yaseen E., Wells P.S., Anderson J., Martin J., and Kovacs M.J. The safety of dosing dalteparin based on actual body weight for the treatment of acute venous thromboembolism in obese patients. J Thromb Haemost 3 (2004) 100-102
19. Dinwoodey D.L., and Ansell J.E. Heparins, low-molecular-weight heparins, and pentasaccharides. Clin Geriatr Med 22 1 (2006) 1-15
20. Tateo S., Mereu L., Salamano S., Klersy C., Barone M., Spyropoulos A.C., and Piovella F. Ovarian cancer and venous thromboembolic risk. Gynecol Oncol 99 1 (2005) 119-125
21. Matsuua Y., Roberston G., Marsden D.E., Kim S.N., Gebski V., and Hacker NF. Thromboembolic complications in patients with clear cell carcinoma of the ovary. Gynecol Oncol 104 2 (2007) 406-410
22. Von Tempelhoff G.F., Pollow K., Schneider D., and Heilmann L. Chemotheraphy and thrombosis in gynecologic malignancy. Clin Appl Thromb Hemost 5 2 (1999) 92-104
23. Nicolaides A. Prevention of venous thromboembolism: international consensus statement guidelines compiled in accordance with the scientific evidence. Int Angiol 20 (2001) 1-37
24. Dainty L., Maxwell G.L., Clarke-Pearson D.L., and Myers E.R. Cost-effectiveness of combination thromboembolism prophylaxis in gynecologic oncology surgery. Gynecol Oncol 93 (2004) 366-373
25. Kemble J.V.H. Incidence of deep venous thrombosis. Br J Hosp Med 6 (1971) 721
26. Flane C., Kakkar V.W., and Clarke M.B. The detection of venous thrombosis of the legs using 125 I-labeled fibrinogen. Br J Surg 55 (1958) 742
27. Hull R.D., Pineo G.F., and MacIsaac S. Low molecular weight heparin prophylaxis: preoperative versus postoperative initiation in patients undergoing elective hip surgery. Thromb Res 101 (2001) V155-V162
28. Martino M.A., George J.G., Murray K., Williamson E., Arora R., Cantor A., et al. Is the addition of pre-operative Enoxaparin (Lovenox) safe to use in patients undergoing Gynecologic Oncologic surgery?. Abstract #358 Society of Gynecologic Oncology Annual Meeting (March 2006)
29. Heit J.A. Low molecular weight heparin: the optimal duration of prophylaxis against postoperative venous thromboembolism after total hip or knee replacement. Thromb Res 101 (2001) V163-V173
30. Hull R.D., Pineo G.F., Francis C., Bergqvist D., Fellenius C., Soderberg K., et al. Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients: a double-blind, randomized comparison. North American Fragmin Trial Investigators. Arch Intern Med 160 (2000) 2208-2215
31. Bergqvist D., Agnelli G., Cohen A.T., Eldor A., Nilsson P.E., Moigne-Amrani A.L., et al. Enoxacan II Investigators. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. NEJM 346 (2002) 975-980
32. Clarke-Pearson D.L., Synan I.S., Coleman R.E., Hinshaw W., and Creasman W.T. The natural history of postoperative venous thromboembolism in gynecologic oncology: a prospective study of 382 patients. Am J Obstet Gynecol 148 (1984) 1051-1054
33. Ramondetta L.M., Tortolero-Luna G., Bodurka D.C., Sills D., Basen-Engquist K., Gano J., et al. Approaches for end-of-life care in the field of gynecologic oncology: an exploratory study. Int J Gynecol Cancer 14 4 (Jul-Aug 2004) 580-588